Besides, several laboratory markers have been approved to be used in breast cancer screening and monitoring, including cancer antigen 15‐3 (CA 15‐3), carcinoembryonic antigen (CEA) and tissue polypeptide‐specific antigen (TPS). Here, CEACAM5 is linked to breast carcinoma.